EPGNY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (22 Sep 2022 @ 00:04):

Stats
आज की मात्रा	212.00
औसत मात्रा	9.00
बाजार मूल्य	0.00
Last Dividend	$0.0297 ( 2021-09-16 )
Next Dividend	$0 ( N/A )
P/E	-1.604
ATR14	$0 (0.00%)

Epigenomics AG सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Epigenomics AG वित्तीय

Annual	2021
राजस्व:	$6.20M
सकल लाभ:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2021
राजस्व:	$6.20M
सकल लाभ:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2020
राजस्व:	$842 000
सकल लाभ:	$697 000 (82.78 %)
EPS:	$-2.48

FY	2019
राजस्व:	$1.13M
सकल लाभ:	$872 000 (77.51 %)
EPS:	$-4.48

Financial Reports:

No articles found.

Epigenomics AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Epigenomics AG Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.458 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.833	2018-10-31
Last Dividend	$0.0297	2021-09-16
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$2.72	--
Avg. Dividend % Per Year	0.00%	--
Score	0.55	--
Div. Sustainability Score	0.458
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-09-23)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.55

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NABZY	Ex Dividend Junior	2023-05-12	Semi-Annually	0.00%
CNLHP	Ex Dividend Junior	2023-08-09	Quarterly	0.00%
TGOPY	Ex Dividend Knight	2023-06-22	Semi-Annually	0.00%
HLFN	Ex Dividend Knight	2023-07-27	Quarterly	0.00%
ANPDY	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
PBSFY	Ex Dividend Junior	2023-06-30	Annually	0.00%
DASTY	Ex Dividend Knight	2023-05-25	Annually	0.00%
UEPEN	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
JFBC	Ex Dividend Knight	2023-08-21	Quarterly	0.00%
BHRB	Ex Dividend Knight	2023-08-14	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.391	1.500	-7.83	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0984	1.200	-3.28	-3.94	[0 - 0.3]
returnOnEquityTTM	-0.187	1.500	-3.19	-4.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	11.06	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	10.72	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	10.72	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0187	-1.500	9.69	-10.00	[0 - 0.6]
interestCoverageTTM	-45.35	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
freeCashFlowPerShareTTM	-0.467	2.00	-0.233	-0.467	[0 - 20]
debtEquityRatioTTM	0.0208	-1.500	9.92	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.978	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.380	1.000	-9.60	-9.60	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-9.03	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.252	0.800	-1.657	-1.325	[0.5 - 2]
Total Score				0.458

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-8.20	1.000	-0.929	0	[1 - 100]
returnOnEquityTTM	-0.187	2.50	-2.05	-4.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.467	2.00	-0.156	-0.467	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.463	1.500	-6.42	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.669	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.63

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.